Cohen-mansfield agitation inventory total score as a measure of agitation and aggression in Alzheimer’s disease: A factor analysis
These findings suggest that assessing agitation and aggression via CMAI domains instead of the total score is likely to miss important behavioral signals. Using total CMAI score in clinical trials and practice, along with the assessment of individual items, is warranted.
Authors
- Suzanne Hendrix (ORCID: https://orcid.org/0000-0002-2374-7727)
- William O. Dawson (ORCID: https://orcid.org/0000-0003-0050-6717)
- Constantine G. Lyketsos (ORCID: https://orcid.org/0000-0003-3827-4720)
- Anton P. Porsteinsson (ORCID: https://orcid.org/0000-0002-0166-1738)
- Bruce L. Brown (ORCID: https://orcid.org/0000-0002-5952-6475)
- Jeffrey L. Cummings (ORCID: https://orcid.org/0000-0001-8944-4158)
- Paul B. Rosenberg (ORCID: https://orcid.org/0000-0003-1106-4299)
- Mary Sano
Institutions
- Brigham Young University (US)
- University of Nevada, Las Vegas (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- James J. Peters VA Medical Center (US)
- TetraLogic Pharmaceuticals (United States) (US)
- University of Rochester (US)
Publication Details
- Journal
- International Psychogeriatrics
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1016/j.inpsyc.2025.100056
- Citations
- 2
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- Alzheimer's Drug Discovery Foundation
- Johns Hopkins University
- National Institute of General Medical Sciences
- National Institute of Neurological Disorders and Stroke